We have shown how transcriptional adaptation is ultimately responsible for PI3K activation upon vertical suppression of the EGFR/MAPK pathway through the upregulation and cooperative activation of different RTKs in a preclinical model of KRAS-mutated colorectal cancer. The gene discussed is PIK3CA; the disease is colorectal cancer.